Charles Schwab’s Foundation Medicine, Inc. FMI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | – | Sell |
-79,831
| Closed | -$10.9M | – | 3164 |
|
|
2018
Q2 | $10.9M | Buy |
79,831
+8,265
| +12% | +$751K | 0.01% | 1537 |
|
|
2018
Q1 | $5.64M | Buy |
71,566
+2,062
| +3% | +$152K | ﹤0.01% | 1875 |
|
|
2017
Q4 | $4.74M | Buy |
69,504
+6,474
| +10% | +$336K | ﹤0.01% | 1943 |
|
|
2017
Q3 | $2.53M | Buy |
63,030
+2,803
| +5% | +$108K | ﹤0.01% | 2210 |
|
|
2017
Q2 | $2.4M | Buy |
60,227
+5,404
| +10% | +$198K | ﹤0.01% | 2159 |
|
|
2017
Q1 | $1.77M | Buy |
54,823
+2,736
| +5% | +$68.3K | ﹤0.01% | 2244 |
|
|
2016
Q4 | $922K | Buy |
52,087
+2,464
| +5% | +$53.1K | ﹤0.01% | 2458 |
|
|
2016
Q3 | $1.16M | Buy |
49,623
+2,176
| +5% | +$49.4K | ﹤0.01% | 2369 |
|
|
2016
Q2 | $886K | Buy |
47,447
+672
| +1% | +$12.1K | ﹤0.01% | 2391 |
|
|
2016
Q1 | $851K | Buy |
46,775
+816
| +2% | +$13.1K | ﹤0.01% | 2392 |
|
|
2015
Q4 | $968K | Sell |
45,959
-6,027
| -12% | -$116K | ﹤0.01% | 2403 |
|
|
2015
Q3 | $960K | Buy |
51,986
+2,782
| +6% | +$69.5K | ﹤0.01% | 2402 |
|
|
2015
Q2 | $1.67M | Sell |
49,204
-3,339
| -6% | -$134K | ﹤0.01% | 2181 |
|
|
2015
Q1 | $2.53M | Buy |
52,543
+4,348
| +9% | +$197K | ﹤0.01% | 1925 |
|
|
2014
Q4 | $1.07M | Buy |
48,195
+12,309
| +34% | +$284K | ﹤0.01% | 2321 |
|
|
2014
Q3 | $681K | Buy |
35,886
+10,220
| +40% | +$244K | ﹤0.01% | 2479 |
|
|
2014
Q2 | $692K | Buy |
25,666
+10,404
| +68% | +$264K | ﹤0.01% | 2500 |
|
|
2014
Q1 | $495K | Buy |
15,262
+360
| +2% | +$11.7K | ﹤0.01% | 2589 |
|
|
2013
Q4 | $355K | Buy |
+14,902
| New | +$417K | ﹤0.01% | 2720 |
|
Charles Schwab's FMI Position: Q3 2018 in Review
Charles Schwab sold out of Foundation Medicine, Inc. (FMI) in Q3 2018, closing a stake of 79,831 shares — an estimated $10.9M sold.
Charles Schwab first reported a position in FMI in Q4 2013 and held it in 19 quarters. The position peaked at $10.9M in Q2 2018. 0 funds tracked by Wall St. Rank hold FMI as of Q3 2018.
- Charles Schwab reported no remaining Foundation Medicine, Inc. position as of Q3 2018 after selling out during the quarter.
- Charles Schwab sold 79,831 Foundation Medicine, Inc. shares in Q3 2018, an estimated $10.9M.
- Charles Schwab first reported a position in Foundation Medicine, Inc. in Q4 2013 and held it in 19 quarters.
- Charles Schwab's Foundation Medicine, Inc. position peaked at $10.9M in Q2 2018.
- 0 funds tracked by Wall St. Rank held Foundation Medicine, Inc. as of Q3 2018.
Based on Charles Schwab's 13F filing for Q3 2018, filed 13 Nov 2018.